Atomera(US:ATOM)2025-10-29 20:45Revenue Performance - Revenue for the three months ended September 30, 2025, was approximately $11,000, a decrease of 50% compared to $22,000 for the same period in 2024[78] - Revenue for the nine months ended September 30, 2025, was approximately $15,000, a decrease of 86.6% compared to $112,000 for the same period in 2024[78] Cost and Expenses - Cost of revenue for the three months ended September 30, 2025, was $128,000, significantly higher than $3,000 for the same period in 2024[79] - Operating expenses for the three months ended September 30, 2025, totaled approximately $5.7 million, an increase of 18.8% compared to $4.8 million for the same period in 2024[80] - Research and development expenses for the three months ended September 30, 2025, were approximately $3.3 million, an increase of 20% compared to $2.8 million for the same period in 2024[82] - General and administrative expenses for the three months ended September 30, 2025, were approximately $2.2 million, an increase of 19% compared to $1.8 million for the same period in 2024[84] - Selling and marketing expenses for the three months ended September 30, 2025, were approximately $207,000, a decrease of 17% compared to $248,000 for the same period in 2024[86] Cash Flow and Financial Position - Net cash used in operating activities for the nine months ended September 30, 2025, was approximately $11.6 million, resulting from a net loss of approximately $15.7 million[92] - As of September 30, 2025, the company had cash and cash equivalents of approximately $20.3 million and working capital of approximately $18.1 million[96] - The company believes its available working capital is sufficient to fund its forecasted working capital requirements for at least the next 12 months[99] Accounting and Risk Disclosures - No changes to critical accounting estimates from the Annual Report on Form 10-K for the year ended December 31, 2024[100] - No applicable quantitative and qualitative disclosure about market risk[101]